Abilify is an antipsychotic drug used to treat symptoms of schizophrenia, Tourette’s, mania, and episodes associated with bipolar disorder but has been linked to compulsive gambling, binge eating, and uncontrollable sexual urges. Causes of action include failure to provide adequate instructions and warning of its risk to the public.

Actemra is used to treat rheumatoid arthritis but has been linked to serious side effects including heart attack, heart failure, stroke, pancreatitis, lung disease, and more. Causes of action include failure to warn the medical community and the public of these risks.

Gadolinium is an MRI contrasting agent and the FDA recently announced requirements for additional warning alerting patients of the potential for gadolinium to be retained in the organs and brain. Evidence suggests that the contrasting agent does not leave the body as quickly as the drug manufacturers promised, and studies show Nephrogenic systemic fibrosis is linked to gadolinium retention whereas the drug is unable to exit the body because the patient suffers from kidney problems.

Janssen Pharmaceuticals and Johnson & Johnson Consumer, Inc. manufacture Imodium, Imodium A-D, Imodium A-D EZ Chews and Imodium Multi-Symptom Relief. The FDA has issued a Drug Safety Advisory Warning stating that consumers are experiencing serious heart problems after consuming high doses of Imodium products.

Invokana (canagliflozin) is a medication used in the treatment of Type II diabetes. Clinical studies in May of 2016 confirmed that the use of Invokana may double the amputation risk. Subsequently, in May of 2017, the FDA issued a black box warning. The use of Invokana can also lead to kidney damage and diabetic ketoacidosis. Causes of action include misrepresentation of the risks in using the drug, and failure to warn of its side effects.

Invokana is a SGLT2 inhibitor that the FDA has warned can lead to a condition known as diabetic ketoacidosis (DKA), characterized by excessive acid levels in the blood in addition to bone breaks and kidney injuries. Plaintiffs argue that Janssen Pharmaceuticals misrepresented the risks, and fail to warn patients about Invokana’s side effects.

The FDA issued a safety alert in August of 2017 halting two Ketruda clinical trials due to patient deaths related to treatment for multiple myeloma. Keytruda is not approved for treatment of multiple myeloma and may be deadly for some patients when treated with a combination of Ketruda, dexamethasone and either of two immunomodulatory agents; lenalidomide or pomalidomide.

In January of 2018 a recall of Limbrel, an osteoarthritis medication, was announced after the FDA warned users to stop taking the drug because it causes potentially life-threatening side effects such as drug-induced liver injury and a lung condition called hypersensitivity pneumonitis – both of which can be fatal.

Class action lawsuit related to how the NCAA handled concussions and failed to protect their student-athletes prior to guidelines created in 2010. NCAA has agreed to set aside $70M medical monitoring fund, $5M towards prevention research, and a change in its return-to-play and concussion management policies.

Nuedexta is approved for treatment of pseudobulbar affect (PBA), a condition that can cause uncontrollable laughing or crying, but has been widely used in nursing homes to calm and sedate dementia patients (aka “chemical restraint”). It is linked to skin reactions, dizziness, comas, and death.

Nuplazid (pimavanserin) was the first drug cleared by the FDA for treatment of hallucinations and delusions associated with Parkinson’s Disease. The approval was expedited by designating Nuplazid a, “breakthrough therapy.” In April of 2016, the FDA approved Nuplazid based on one 6-week clinical trial of 200 patients. That particular study showed patients were twice as likely to die or suffer serious adverse events. Three previous clinical trials failed to show a benefit in reducing hallucinations associated with Parkinson’s.

Ocaliva (obeticholic acid) was FDA approved as a new drug in May of 2016 for the treatment of primary biliary cholangitis. The FDA warning in September of 2017 referred to labeling changes that should warn of the risks of liver decompensation, liver damage, liver failure and possibly death in patients with primary biliary cholangitis (PBC) with moderate to severe hepatic impairment.

Onglyza is a Type 2 diabetes medication for controlling blood sugar, but is linked to increased risk of heart failure.

Proton pump inhibitors (PPI) are medications designed to treat certain gastrointestinal disorders, but the risks include kidney damage, heart attacks, and premature death. More than a hundred million dollars has been paid to settle lawsuits claiming the manufacturers failed to warn people of the risks for years.

Risperdal is an antipsychotic drug used to treat schizophrenia and bipolar disorder but is linked to male breast tissue enlargement (gynecomastia). Its label also includes a black box warning, the strongest drug warning in the U.S. Millions of dollars have been awarded in jury verdicts.

Tasigna is an FDA approved chemotherapy drug for the treatment of specific types of leukemia. Causes of action include failure to warn that the leukemia drug has been linked to severe and irreversible atherosclerosis — hardening and narrowing of the arteries — and related conditions.

Taxotere is a chemotherapy drug that breast cancer survivors are suing Sanofi-Aventis U.S. LLC, makers of Taxotere, claiming the company failed to warn them of the permanent hair loss risk associated with Taxotere. It has also been approved to treat lung, prostate, stomach, and head and neck cancers. Also linked to toxic deaths and other life-threatening side effects. It is one of the most prescribed drugs in its class. Two causes of action: Promoting Sales at Patient’s Expense, and Loss of Quality of Life (due to psychological effects of hair loss).

Several testosterone replacement drugs are being sued for failure to fully investigate the risks, which include heart attack and stroke; failure to warn doctors and patients of the risks, and the use of aggressive marketing tactics that do not provide enough warning about the serious health risks.

The FDA recently released a public warning about the risk of Uloric causing cardiac arrest, and required a post-market study based on original warning label references to increased risk of heart attack and cardiac-related deaths.

Varubi is an anti-nausea drug used for chemotherapy patients and can be administered in either pill or IV form. Varubi reportedly causes numerous hypersensitivity reactions like an anaphylactic shock as well as swelling of the face and throat, difficulty breathing, wheezing, hives that typically occur within a few minutes after Varubi is administered. Purportedly patients with existing allergies to legumes, soybean oil and other related allergens are at higher risk, which points to the insufficient labeling of the drug.

Viberzi is a drug used to treat irritable bowel syndrome (IBS) with diarrhea in some adults. Causes of action include failure to properly warn patients of its risks which includes pancreatitis and even death. B37:B38

Xarelto is a medication used as a blood thinner to prevent blood clots and protect people from strokes but may cause irreversible internal bleeding that can lead to hospitalization and death. There is no bleeding antidote for Xarelto. Millions of dollars have been awarded in verdicts.

Attune Knee System is a knee replacement system. The cause of action is premature device failure, some within months of surgery. Loosening of the implants can cause pain, swelling and main lead to serious accidents.

Benzene is a chemical often found in industrial sites and used to manufacture rubber, plastics, lubricants, paints, gas, synthetics, etc. Short-term exposure can cause death, dizziness, confusion, immune system depression, anemia. Long-term can lead to various cancers, and often attributed to most blood cancers: Leukemia, Non-Hodgkins Lymphoma, etc.

Essure is a permanent birth control system for women, and according to court documents Bayer’s product was manufactured with defects causing pain or bleeding, device migration or fracture, and organ piercing.

GM faulty ignition switches are linked to hundreds of accidents leading to injuries and deaths. The automaker has paid more than a billion dollars to settle lawsuits.

Hernia mesh is a screen-like surgical implant used to repair hernias, however, the mesh can lead to infections and serious complications like mesh migration, fluid building around the implant, bowel piercing, and chronic pain. Lawsuits have resulted in millions of dollars in verdicts and settlements, even as more people file new lawsuits.

IVC Filters are small, metal devices designed to stop blood clot from traveling to the lungs and causing pulmonary embolism, however, the devices can become dislodged leading to serious organ damage, health complications, and even death.

Mirena is a birth control device linked to causing organ piercing, device migration, and misplacement. Causes of action include deceptive advertisement and failure to properly warn of the risks. +B17:B18

Metal-on-metal (MoM) hip implants are devices that are associated with pain and swelling, and can lead to revision surgeries and even permanent health problems. Hundreds of millions of dollars have been agreed to be paid out to settle claims that the devices were defective.

The NeuroBlate probe is used during a variety of complex neurological surgeries. The device is currently the subject of a Class I Recall by the FDA because of several instances of unintended heating and damage to the probe and surrounding brain tissue.

A class action lawsuit against Remington Rifles claims that the trigger mechanisms with a component part, the trigger connector, are defectively designed and can result in accidental discharges without the trigger being pulled.

Monsanto’s Roundup Weed and Grass Killer is the most popular herbicide in the world, but studies have shown an association with increased risk of cancer (exposure to glyphosate): Non-Hodgkin Lymphoma, as well as multiple myeloma, and leukemia. Causes of action include failure to warn consumers of the risks, and misinforming the public of its safety

Talcum Powder is used to treat diaper rash, absorb moisture, and as a deodorant. New research has found traces of asbestos in the powder linking talc use to ovarian cancer. Specifically, Johnson & Johnson is currently fighting more than 9,000 lawsuits for its baby powder, and billions of dollars have been awarded as of 2018.

An FDA recall has been issued for the Venture Catheter, which was manufactured between 2015 and 2017. The excess material at the tip of the catheter has been shown to separate and cause serious adverse consequences like blood clots, embolism of the excess material to vital organs, and even death.

Hurricane Harvey left tens of thousands of victims flooded upstream, and another several thousand victims flooded downstream from reservoir waters, for a collective financial loss projected to exceed a billion dollars.

Hurricane Harvey left tens of thousands of victims flooded upstream, and another several thousand victims flooded downstream from reservoir waters, for a collective financial loss projected to exceed a billion dollars.